Lidco sell hemodynamic monitoring products for patients in critical care situations (in surgery or intensive care). The technology monitors fluid balance, and reduces unwanted side effects of major surgery, often enabling patients to have a much reduced stay in hospital. There are therefore substantial cost benefits for hospitals who implement such technology. For example an NHS report recently recommended wider adoption of fluid management technologies – full adoption across the NHS might result in £400m per annum of savings. The worldwide market potential is obviously even larger. After the initial sale of a monitor, the company gets on-going revenue from disposable items and other repeat revenue, so new monitor sales are now a relatively small proportion of total sales, with the installed base being the critical number. I attended the
...Not a member? Join today
Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:
Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities
Already a member?
Log in to your account to access this content and all of your other ShareSoc membership benefits.